Boardroom Alpha
Boardroom Alpha
BARK · Current Report (Form 8-K) · Filed March 26, 2026

Bark Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 26, 2026
Period
Mar 25, 2026
Ticker
BARK
Accession
0001628280-26-021415
Boardroom Alpha · Filing insights

Stockholders elected two Class A directors and approved a 1-for-20 reverse stock split, effective April 1, 2026.

About Bark Inc
Market cap
$86M
1Y TSR
−52.2%
3Y TSR
−29.3%
Board grade
C-
Sector
Consumer Cyclical
CEO
Matt Meeker
Last annual meeting: Sep 12, 2024 · View full Bark Inc profile →
bark-20260325

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date Earliest Event Reported):
March 25, 2026
 
BARK, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware 001-39691 85-1872418
(State or Other Jurisdiction
of Incorporation)
 (Commission File Number) (IRS Employer Identification No.)
20 Jay Street, Suite 940
Brooklyn, NY
 
11201
(Zip Code)
(Address of Principal Executive Offices) 
(855) 501-2275
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 
Trading
Symbol(s)
 
Name of each exchange on
which registered
Common Stock, par value $0.0001 BARK New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07. Submission of Matters to a Vote of Security Holders.

On March 25, 2026, BARK, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to consider and vote on the proposals set forth below, each of which is described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on February 12, 2026. The final voting results are set forth below.

Proposal 1

Election of Class A Director Nominees

The stockholders elected the persons named below as Class A directors to serve a three-year term ending at the Company’s 2028 annual meeting and until his or her successor is elected and qualified. The results of such vote were as follows:

Director NomineeForWithholdBroker Non-Votes
Betsy McLaughlin85,410,45015,907,57339,971,183
Henrik Werdelin90,493,97710,824,04639,971,183

Proposal 2

Ratification of Appointment of Independent Registered Public Accounting Firm

The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2026. The results of such vote were as follows:

ForAgainstAbstainBroker Non-Votes
99,180,6574,086,60138,021,948N/A

Proposal 3

Advisory Vote to Approve the Compensation of the Company's Named Executive Officers

The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of such vote were as follows:

ForAgainstAbstainBroker Non-Votes
60,101,23614,022,63127,194,15639,971,183

Proposal 4

Approval of an Amendment to the Restated Certificate of Incorporation that Would Effect a Reverse Stock Split at a Ratio Between 1:2 and 1:30, if and When Determined by the Board of Directors (the “Reverse Stock Split Proposal”)

The stockholders approved the Reverse Stock Split Proposal. Approval of this proposal required that the votes cast “for” the proposal must exceed the votes cast “against” the proposal.

ForAgainstAbstainBroker Non-Votes
83,955,16157,254,74779,298N/A





Item 7.01 Regulation FD Disclosure.

On March 26, 2026, the Company issued a press release, a copy of which is attached as Exhibit 99.1 hereto. The information contained in this Item 7.01, including Exhibit 99.1 furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 8.01 Other Events.

On March 26, 2026, the Company announced that its Board of Directors approved a one-for-twenty (1:20) reverse stock split of its common stock (the “Reverse Stock Split”). The Reverse Stock Split is expected to become effective on April 1, 2026 (the “Effective Time”), with shares to begin trading on a split-adjusted basis at market open. In connection with the Reverse Stock Split, every 20 shares of the Company’s common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company’s common stock. No fractional shares will be issued in connection with the Reverse Stock Split. The Company’s stockholders will be entitled to receive the cash value equal to the fraction to which the stockholder would otherwise be entitled, multiplied by the closing price of the common stock, as reported by the New York Stock Exchange, on the last trading day prior to the effective date of the Reverse Stock Split.

As a result of the Reverse Stock Split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding equity awards and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the exercise or conversion price, as applicable.


Item 9.01    Financial Statements and Exhibits

(d) Exhibits

Exhibit No.Description
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

BARK, Inc.
By:/s/ Allison Koehler
Name: Allison Koehler
Title: Chief Legal Officer
Date: March 26, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bark Inc (BARK)

Reference

Frequently asked questions

When did Bark Inc file this 8-K?
Bark Inc (BARK) filed this Current Report (Form 8-K) with the SEC on March 26, 2026. The accession number assigned by EDGAR is 0001628280-26-021415.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected two Class A directors and approved a 1-for-20 reverse stock split, effective April 1, 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Bark Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Bark Inc has filed under CIK 1819574, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer